A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Public ClinicalTrials.gov record NCT07265479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.
Study identification
- NCT ID
- NCT07265479
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 187 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Months to 23 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2025 (Actual)
- Primary completion
- Aug 2027 (Estimated)
- Completion
- Aug 2027 (Estimated)
- Last update posted
- Oct 5, 2026
2025 – 2027
United States locations
- U.S. sites
- 36
- U.S. states
- 24
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AllerVie Clinical Research | Birmingham | Alabama | 35209 | — |
| Dermatology Trial Associates | Bryant | Arkansas | 72022 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Integrative Skin Science and Research | Sacramento | California | 95815 | — |
| Allergy and Asthma Medical Group and Research Center | San Diego | California | 92123 | — |
| Clinical Trials Research Institute | Thousand Oaks | California | 91320 | — |
| Clarity Dermatology | Castle Rock | Colorado | 80109 | — |
| Skin Care Research, LLC. | Boca Raton | Florida | 33486 | — |
| APEX Clinical Trials | Jacksonville | Florida | 32256 | — |
| TruDerm Research | Wellington | Florida | 33449 | — |
| Cleaver Medical Group Dermatology, Inc | Cumming | Georgia | 30040 | — |
| Ada West Research | Meridian | Idaho | 83646 | — |
| Endeavor Health Clinical Trials Center | Skokie | Illinois | 60077 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| Equity Medical, LLC | Bowling Green | Kentucky | 42104 | — |
| Lawrence J Green, MD LLC | Rockville | Maryland | 20850 | — |
| Oakland Hills Dermatology | Auburn Hills | Michigan | 48326 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| SKY Integrative Medical Center | Ridgeland | Mississippi | 39157 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Skin Cancer and Dermatology Institute | Reno | Nevada | 89509 | — |
| Forest Hills Dermatology Group | Kew Gardens | New York | 11415 | — |
| Bobby Buka MD, PC | New York | New York | 10012 | — |
| Equity Medical, LLC | The Bronx | New York | 10455 | — |
| The University of North Carolina Dermatology and Skin Cancer Center | Chapel Hill | North Carolina | 27516 | — |
| Dermatologists of Central States, LLC | Fairborn | Ohio | 45324 | — |
| Allergy Asthma and Clinical Research Center | Oklahoma City | Oklahoma | 73120 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| National Allergy and Asthma Research, LLC. | North Charleston | South Carolina | 29420 | — |
| The University of Texas Health Science Center at Houston | Bellaire | Texas | 77401 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Stryde Research - Epiphany Dermatology | Southlake | Texas | 76092 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07265479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07265479 live on ClinicalTrials.gov.